NCT06456801已完成不适用
Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)
Zhejiang University1 个研究点 分布在 1 个国家目标入组 219 人开始时间: 2021年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 219
- 试验地点
- 1
- 主要终点
- Calculate the correlation between the test reagents and comparison reagents
研究概览
简要总结
Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.
详细描述
Conduct comparative experimental studies on clinical serum samples using assessment reagents and approved products, and evaluate the equivalence between assessment reagents and comparison reagents.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clear background information and traceable sources of samples from kidney disease patients (number, age, gender, and clinical diagnostic information).
排除标准
- •Exclude serum samples that meet one of the following conditions:
- •① Samples with insufficient sample size, ② Samples with incomplete sample information.
结局指标
主要结局
Calculate the correlation between the test reagents and comparison reagents
时间窗: 1 year.
Calculate the correlation between the test reagents and comparison reagents
次要结局
未报告次要终点
研究者
Du Xiaoying
Department of nephrology
Zhejiang University
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)Membranous Nephropathy - PLA2R InducedKidney Diseases-except Membranous NephropathyNCT05861869Zhejiang Biostar Biotechnology Co.450
招募中
2 期
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck CancerHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck NeoplasmsHead CancerThroat CarcinomaNCT05420948University of Chicago30
已完成
1 期
Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and LymphomasSolid TumorsLymphomasNCT02740270Novartis Pharmaceuticals92
已完成
2 期
Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle VaccineNorovirusHealthy ParticipantsNCT02475278Takeda50
已完成
1 期
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid TumorsSolid TumorsNCT01949688Shiga University26